Research and Markets - Global Clinical Chemistry Analyzers Market Analysis 2014-2017 & 2025: Key Players are Mindray Medical International, Johnson & Johnson and F.Hoffmann-La Roche

DUBLIN, Apr. 25, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Clinical Chemistry Analyzers Market Analysis By Product (Analyzers, Reagents), By Test (BMP, Electrolyte Panel, Liver Panel, Lipid Profile, Renal Profile, Thyroid Function Profile, Specialty Test), By End Use, And Segment Forecasts, 2014-2025" report to their offering.

The global clinical chemistry analyzers market is expected to reach USD 16.0 billion by 2025

The growing prevalence of chronic diseases is anticipated to be responsible for the high urgency to adopt clinical chemistry analyzers, which thereby widens the scope for growth during the forecast period. In addition, growing base of geriatric and bariatric population, which is highly susceptible to chronic diseases, is presumed to impel the demand further. Consequently, the resultant high sample volume requiring high capability analyzing devices is driving the market growth.

Moreover, increasing awareness pertaining to benefits associated with these devices is also a high impact rendering driver for clinical chemistry analyzers market. Advent of advanced chemistry analyzers has resulted in improved point-of-care testing capabilities, and thus created high potential growth opportunities for the market. In addition, technological advancements in preanalytical, analytical, and post analytical stages due to analyzing devices & reagents improved their diagnostic capabilities and overall efficiency, which is predicted to propel the growth further. These advancements include advent of microchips, sensors, chemometrics, and robotics. Furthermore, consistent efforts by public as well private healthcare organizations to increase the reliability of data have rapidly engendered the integration of automated chemistry analyzers and immunoassay systems, thereby resulting in overall reduction of workload in laboratories, thus propelling the demand.

Further Key Findings From the Study Suggest:

• Reagents held a substantial share in product segment in 2015. The substantial share can be attributed to increasing reagent rental agreements and availability resulting in quick global access
• Lipid panel is anticipated to exhibit lucrative CAGR during the forecast period owing to increasing adoption, as the demand for screening tests for cholesterol and triglyceride levels in case of cardiovascular disorders and diabetes has increased
• In 2016, North America accounted for substantial share in the global clinical chemistry analyzers market, as a consequence of local presence of prominent companies involved in high R&D investments
• Asia Pacific is anticipated to grow at an exponential CAGR due to unmet patient needs, continuous technological & infrastructural upgradation, and growing healthcare expenditure
• Some key participants such as Mindray Medical International Ltd.; Johnson & Johnson; and F.Hoffmann-La Roche Ltd. are undertaking various sustainability strategies, such as new product development & frequent product approvals, to gain competitive advantage
• For instance, in August 2016, Mindray announced the premarket FDA clearance for Mindray BA-800M clinical chemistry analyzer allowing it to distribute its product

Key Topics Covered:

1 Research Methodology & Scope
1.1 Region Wise Market Calculation
1.1.1 Region-wise market: Base estimates
1.1.2 Global market: CAGR calculation
1.2 Region-Based Segment Share Calculation
1.3 List of Secondary Sources

2 Executive Summary

3 Clinical Chemistry Analyzers Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.3 Market Restraint Analysis
3.4 Penetration & Growth Prospect Mapping
3.5 Clinical Chemistry Analyzers Market - SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
3.6 Industry Analysis - Porter's

4 Clinical Chemistry Analyzers Market: Product Estimates & Trend Analysis
4.1 Clinical Chemistry Analyzers Market: Product Movement Analysis
4.2 Analyzers
4.2.2 Small analyzers
4.2.3 Medium analyzers
4.2.4 Large analyzers
4.2.5 Very large analyzers
4.3 Reagents
4.3.2 Calibrators
4.3.3 Controls
4.3.4 Standards
4.3.5 Others
4.4 Others

5 Clinical Chemistry Analyzers Market: Test Estimates & Trend Analysis
5.1 Clinical Chemistry Analyzers Market: Test Movement Analysis
5.2 Metabolic Panels
5.3 Specialty Chemical Tests
5.4 Thyroid Function Tests
5.5 Lipid Profiles
5.6 Electrolyte Panels
5.7 Liver Panels
5.8 Renal Profiles

6 Clinical Chemistry Analyzers Market: End-Use Estimates & Trend Analysis
6.1 Clinical Chemistry Analyzers Market: End-Use Movement Analysis
6.2 Hospitals
6.3 Academic Research Centers
6.4 Diagnostic Laboratories
6.5 Others

7 Clinical Chemistry Analyzers Market: Regional Estimates & Trend Analysis, by Product, Test & End-Use

8 Competitive Landscape

• Mindray Medical International Limited
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Geographic Foothold
• Abbott Laboratories
• Johnson & Johnson
• Siemens AG
• F.Hoffmann-La Roche Ltd.
• Elitech Group
• Horiba, Ltd.
• Randox Laboratories

For more information about this report visit http://www.researchandmarkets.com/research/kbqjgr/clinical

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[e-mail]

For E.S.T Office Hours Call [phone]
For U.S./CAN Toll Free Call [phone]
For GMT Office Hours Call [phone]

U.S. Fax: [phone]
Fax (outside U.S.): [phone]